Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05976347 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Identifying and Treating Depression in the Orthopaedic Trauma Population

StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary and study completion pushed from May 2026 to May 2027v16
  2. Re-verified, no change to tracked fieldsv15
  3. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Jul 2025 to Jun 25, 2025
    • Site details revised
    v14
  4. Start date: Apr 2025 to Jul 2025
    • Primary and study completion dates: Feb 2026 to May 2026
    v13
  5. Start date: Jan 2025 to Apr 2025v12
Show 10 earlier versionsHide 10 earlier versions
  1. Start date: Nov 2024 to Jan 2025
    • Primary and study completion dates: Dec 2025 to Feb 2026
    v11
  2. Start date: Sep 2024 to Nov 2024v10
  3. Start date: Jul 2024 to Sep 2024v9
  4. Start date: May 2024 to Jul 2024v8
  5. Start date: Apr 2024 to May 2024v7
  6. Start date: Feb 2024 to Apr 2024v6
  7. Start date: Dec 2023 to Feb 2024v5
  8. Start date: Oct 2023 to Dec 2023v4
  9. Start date: Aug 2023 to Oct 2023v3
  10. Re-verified, no change to tracked fieldsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this trial is to pilot a way for orthopaedic surgeons to safely screen for depression and provide treatment for depression with medication. The main questions it aims to answer are: 1. What are the outcomes of patients who screen positive for depressive symptoms and are prescribed either an Selective serotonin reuptake inhibitors (SSRI) or serotonin and norepinephrine reuptake inhibitors (SNRI). 2. What are the outcomes of patients who screen positive for depressive symptoms and choose not to pursue treatment with medication?
Trial Details
NCT Number NCT05976347
Lead Sponsor Wake Forest University Health Sciences
Conditions
(from sponsor)		 Depression
Related terms Depression
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov